Melatonin may slow disease progression in amyotrophic lateral sclerosis: Findings from the Pooled Resource Open‐Access ALS Clinic Trials database-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Melatonin may slow disease progression in amyotrophic lateral sclerosis: Findings from the Pooled Resource Open‐Access ALS Clinic Trials database

Published:2021-01-24 Issue:4 Volume:63 Page:572-576
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle & Nerve

Author:

Bald Elizabeth M.¹,Nance Christopher S.²,Schultz Jordan L.³

Affiliation:

1. Department of Pharmacotherapy University of Utah College of Pharmacy Salt Lake City Utah

2. Department of Neurology Carver College of Medicine at the University of Iowa Iowa City Iowa

3. Department of Psychiatry Carver College of Medicine at the University of Iowa Iowa City Iowa

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.27168

Reference17 articles.

1. Dose-ranging study of riluzole in amyotrophic lateral sclerosis

2. A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis

3. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

4. Oxidative damage in the central nervous system: protection by melatonin

5. The neuroprotective role of melatonin in neurological disorders

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Presence of melatonin in foods of daily consumption: The benefit of this hormone for health;Food Chemistry;2024-11

2. Unraveling mitochondrial dysfunction: comprehensive perspectives on its impact on neurodegenerative diseases;Reviews in the Neurosciences;2024-08-20

3. Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies;European Journal of Medicinal Chemistry;2024-06

4. Melatonin: a ferroptosis inhibitor with potential therapeutic efficacy for the post-COVID-19 trajectory of accelerated brain aging and neurodegeneration;Molecular Neurodegeneration;2024-04-19

5. Current potential pathogenic mechanisms of copper-zinc superoxide dismutase 1 (SOD1) in amyotrophic lateral sclerosis;Reviews in the Neurosciences;2024-02-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3